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Abstract
Background: Anemia is common in elderly people and especially in nursing home residents. Few studies have
been performed on the consequences of anemia in a nursing home population. This study explored the prevalence
of anemia in nursing homes in Sweden, including risk factors and mortality associated with anemia or hemoglobin
(Hb) decline.
Methods: Three hundred ninety patients from 12 nursing homes were included during 2008–2011. Information
about medication, blood samples, questionnaire responses and information about physical and social activities was
recorded. The baseline characteristics of the patients were compared for subjects with and without anemia. Vital
status was ascertained during the following 7 years from baseline to compare the survival. Hb levels <120 g/L in
women and <130 g/L in men were used to define anemia. For 220 of the subjects Hb change during one year was
registered and the quartiles in Hb change were compared in terms of baseline characteristics and mortality.
Results: The prevalence of anemia at baseline was 52% among men and 32% among women. The men with anemia
had a two-year mortality significantly higher (61%) than the men without anemia (29%, p = 0.001) but there was no
statistical difference in two-year survival in women. In anemic men there was a higher mortality (Hazard Ratio = 1.58)
during a total follow-up period of up to 7 years after adjustment for age, increased B-type natriuretic peptide (BNP) and
decreased estimated Glomerular Filtration Rate (eGFR). Among men, but not women, we found baseline correlations
between anemia and elevated BNP (>100 ng/L) and severely reduced eGFR (<30 ml/min). When the lowest quartile of
Hb change (decline > 9 g/L) was compared with the highest (improvement > 6 g/L) the mortality was higher in the
lowest quartile (p = 0.03).
Conclusions: Anemia is common in nursing home residents in Sweden, especially among men for whom it is related
to higher mortality. A rapid Hb drop is associated with higher mortality. Regardless of earlier Hb values, monitoring Hb
regularly in a nursing home population seems important for catching rapid Hb decline correlated with higher mortality.
Keywords: Anemia, Mortality, Elderly, Nursing homes, Longitudinal study
Background
Anemia is a common medical condition which is con-
sidered a global health problem as it affects both developed
and developing countries and all ages [1, 2]. Anemia is
more common among older persons and the prevalence in-
creases with advancing age [3–6]. Anemia in older adults is
frequently associated with negative outcomes, including
decreased physical performance, increased number of falls,
increased frailty, increased hospitalization, increased cogni-
tive impairment and increased mortality [7].
Anemia is defined by the World Health Organization
(WHO) as hemoglobin (Hb) < 120 g/L in women and
< 130 g/L in men [8]. These limits are established
worldwide and used in the vast majority of publica-
tions on this topic [5]. The WHO limits have also been
questioned, however, due to few stated references, the
small number of reference subjects, and some methodo-
logical problems [9]. The relevance of the WHO limits in
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older adults has also been discussed as the reference
sample was aged < 65 years [10]. Lower anemia limits for
elderly patients in general have been suggested [11] as well
as equal limits (i.e. lower limits for older men) for both
sexes among the oldest old [12] and higher decision limits
among older adults [13]. Older men have a tendency to
have a slightly higher prevalence of anemia than women,
which has been suggested to be a result of the sex specific
limits [14]. Lower Hb limits in premenopausal women
seem motivated due to menstrual blood losses, but could
consequently be questioned in older women [13]. On the
other hand, higher levels of androgens in men stimulate
the hematopoietic system by various mechanisms and is
correlated with the Hb level [15]. Still, despite being
debated, the WHO limits are found appropriate and clini-
cally relevant by several authors for older persons as well
[5, 10, 16].
In a large community-based US population study
(the Third National Health and Nutrition Examination
Survey, NHANES III) 11.0% of the men and 10.2% of
women aged 65 years and older were anemic. Among
those older than 85 years 26% of men and 20% of
women were anemic [14]. In NHANES III there are
also considerable differences in anemia prevalence due
to ethnicity [13]. The Health Survey for England (HSE)
found a similar anemia prevalence among people over
65 years [10].
In older nursing home residents the reported prevalence
of anemia is higher, between 48 and 67% [5, 17–22], com-
pared to population-based studies. Among women in
nursing homes the occurrence varies between 49 and 65%
[17, 19, 20, 22, 23] and among men between 45 and 70%
[17, 19, 20, 22].
Low levels of Hb are considered a marker of disease
and associated with increased mortality [4, 16, 24]. Some
studies indicate that low levels of Hb are a stronger risk
factor for mortality in men than in women [10, 16, 25].
Even mild anemia is shown to be associated with a
higher mortality rate in elderly persons [25].
The main causes of anemia in the elderly population
are nutrient-deficiency-related anemias, anemia due to
chronic disease or chronic inflammation and anemia
due to chronic kidney disease (CKD), but there is also a
high rate of unexplained anemia [4, 14]. In nursing home
residents CKD has been highlighted as an important cause
of anemia [18, 20, 21, 26].
It is widely held that there is a need for more research
on how to interpret levels of Hb in the oldest old with
frailty [4, 5, 27].
The aim of this study was to explore the prevalence
of anemia in an elderly Swedish population living in
nursing homes, with special consideration of risk fac-




The Study of Health and Drugs in the Elderly (SHADES)
was a longitudinal cohort study of elderly people living
in 12 different nursing homes in three cities in the south
of Sweden (Jönköping, Linköping, and Eslöv). The aim
of the SHADES study was to describe and analyze the
morbidity, mortality, laboratory findings and pharmaceuti-
cal treatment of elderly residents in nursing homes and to
use the data collected to improve health care [28].
In the 12 selected nursing homes all residents were in-
vited to join the study. When a resident living in one of
the nursing homes moved or died, the next person who
moved in to the nursing home was invited to participate.
During 2008–2011, 428 patients were included in the
SHADES study. Persons living in a nursing home only
temporarily for palliative care or short-term rehabilita-
tion were excluded, as well as individuals with language
difficulties and persons under the age of 65. Written in-
formed consent was obtained from all participants. For
those participants who could not understand the infor-
mation and give informed consent due to cognitive
impairment this was obtained from next of kin.
Methods of investigation
Participants were examined at baseline by specially
trained nurses who also collected data from patient
records for current medical treatment. The in-person
testing of participants was performed by the study
nurses with assistance of the staff at the nursing home
and included measurement of weight and height. The
Mini Mental State Examination (MMSE) [29] was used
to measure cognitive function. MMSE assesses cognitive
function through a number of questions directed to the
participant regardless of cognitive function. Nutrition
status was assessed through Short-form Mini-nutritional
assessment (MNA-SF) [30]. Nutrition assessment with
the MNA scale does not require cooperation from the
participant, but information from the nursing home
staff. Time weekly for physical activities and social ac-
tivities for each individual was estimated by the staff of
the nursing home. Blood samples were drawn according
to a standard procedure. In 390 of the 428 included
subjects baseline Hb analysis was performed. The ana-
lyses of Hb were performed in connection with the
sampling in the local laboratories of the hospitals in
Jönköping, Linköping and the Health Center in Eslöv.
Reasons for a missing Hb analysis were lack of patient
collaboration or blood sampling difficulties. The num-
bers of participants included, excluded, or missing in
the different parts of study are illustrated in Fig. 1.
Remaining blood samples were stored at −70 °C in a
freezer. Levels of creatinine, cystatin C, B-type natri-
uretic protein (BNP), transthyretin, C-reactive protein
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(CRP), ferritin, and transferrin were analyzed at the la-
boratory in the County Hospital Ryhov in Jönköping
by high-pressure liquid chromatography. For BNP,
transthyretin, CRP, ferritin, and transferrin we used the
routine cut-off values suggested by the laboratory. For
assessing renal function we used the formula for esti-
mating glomerular filtration rate (GFR) according to
recently updated Swedish guidelines [31]. The esti-
mated GFR (eGFR) was defined as the average of (1)
the GFR estimated from creatinine based on the revised
equations for estimating GFR from the Lund-Malmö
Study cohort [32] and (2) the GFR estimated from
cystatin C with the CAPA formula [33].
We also followed the subjects during a follow-up time
of up to 7 years after inclusion with death dates from
the Swedish population register.
The population with 12-month follow-up values for
Hb was divided into quartiles according to change in Hb
value. The lowest quartile of Hb change (decline > 9 g/L)
was compared to the highest (improvement > 6 g/L) in
terms of baseline characteristics and mortality.
Statistical analysis
All statistical analyses were performed using SPSS Statis-
tics version 23 (SPSS, Inc. Chicago, IL). Since we as-
sumed that the mean values were normally distributed
we used Student’s T-test for continuous variables and we
used the Chi-squared test for discrete variables. Survival
analysis was performed using Cox regression (propor-
tional hazards analysis) with a follow up time of up to
about 7 years, the subjects still alive 1 January 2016 were
considered as censored.
Results
There were 276 women (71%) and 114 men (29%) in the
study cohort. The mean age at inclusion was 85.1 years
(±6.8) with a range between 65 and 101 years. The female
subjects were older (85.9 ± 6.6 years) than the male sub-
jects (83.0 ± 6.7, p < 0.001).
According to the WHO limits 52% of the men and 32%
of the women had anemia (130 and 120 g/l respectively).
When we used the same anemia limit for men as for the
women (120 g/L) the anemia occurrence was considerably
lower (27%), with no significant difference from women
(p = 0.325). The women with anemia according to the
WHO limits were significantly older than the non-anemic
women. Men had the same tendency but the age dif-
ference was not significant.
There were no significant differences in weight, height,
BMI, time for physical activity, or social activity between
women with and without anemia. Among men, the only
difference was that the men with anemia were less physi-
cally active. On average study subjects were taking 6.8
drugs daily and no statistically significant differences
were observed between men and women or subjects
Fig. 1 Flow chart of patients in the SHADES study
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Table 1 Baseline characteristics of the women and men with and without anemia
Women
Parameter All (n = 276) Anemia (A) = Hb < 120 g/L (n = 89) Nonanemic (NA) (n = 187) p-value (A vs. NA)
100% 32.2% 67.8%
Age (years) mean ± SD 85.9 ± 6.6 87.1 ± 6.0 85.4 ± 6.8 0.037
Hb (g/L) mean ± SD 124.5 ± 13.6 109.0 ± 7.5 131.8 ± 8.7 <0.001
Weight (kg) mean ± SD 63.9 ± 14.0 62.0 ± 13.7 64.7 ± 14.1 0.137
Height (cm) mean ± SD 159.6 ± 6.8 159.0 ± 6.5 159.8 ± 6.9 0.370
BMI (kg/m2) mean ± SD 25.0 ± 5.0 24.6 ± 5.2 25.3 ± 5.0 0.296
Physical activity (h/week) mean ± SD 0.51 ± 0.76 0.43 ± 0.69 0.54 ± 0.79 0.246
Social activity (h/week) mean ± SD 1.97 ± 2.32 1.97 ± 2,28 1.97 ± 2,34 0.983
Medications in total ± SD 6.8 ± 3.0 7.0 ± 3,3 6.7 ± 2,9 0.442
Warfarin 7.2% (n = 20) 3.4% (n = 3) 9.1% (n = 17) 0.087
ASA 50.7% (n = 140) 46.1% (n = 41) 52.9% (n = 99) 0.286
SSRI 35.1% (n = 97) 39.3% (n = 35) 33.2% (n = 62) 0.316
NSAID 1.8% (n = 5) 1.1% (n = 1) 2.1% (n = 4) 0.554
BNP > 100 ng/L (n = 273) 50.5% 55.7% 48.1% 0.242
eGFR < 60 mL/min (n = 273) 61,9% 67.4% 59.2% 0.192
eGFR < 30 mL/min (n = 273) 7.0% 11.2% 4.9% 0.053
Transthyretin < 0.23 g/L (n = 272) 59.9% 68.5% 55.7% 0.043
CRP ≥ 10 mg/L (n = 275) 31.6% 46.6% 24.6% <0.001
Ferritin > 204 μg/L (n = 276) 17.8% 25.8% 13.9% 0.015
Transferrin < 1.9 g/L (n = 275) 4.7% 6.8% 3.7% 0.262
Men
Parameter All (n = 114) Anemia (A) = Hb < 130 g/l (n = 59) Nonanemic (NA) (n = 55) p-value (A vs NA)
100% 51.8% 48.2%
Age (years) mean ± SD 83.0 ± 6.7 84.2 ± 6.3 81.8 ± 7.0 0.064
Hb (g/L) mean ± SD 128.6 ± 15.4 117.1 ± 9.0 140.9 ± 10.6 <0.001
Weight (kg) mean ± SD 73.9 ± 13.1 71.9 ± 11.9 76.0 ± 14.0 0.095
Height (cm) mean ± SD 173 ± 6.7 172.4 ± 6.6 172.7 ± 6.9 0.811
BMI (kg/m2) mean ± SD 24.8 ± 4.3 24.2 ± 4.1 25.4 ± 4.3 0.129
Physical activity (h/week) mean ± SD (n = 109) 0.58 ± 0.94 0.39 ± 0.71 0.78 ± 1.11 0.030
Social activity (h/week) mean ± SD (n = 109) 1.19 ± 1.94 1.04 ± 1.98 1.35 ± 1.89 0.401
Medications in total 7.1 ± 3.2 7.6 ± 3,3 6.6 ± 3,0 0.078
Warfarin 11.3% (n = 13) 11.7% (n = 7) 10.9% (n = 6) 0.873
ASA 56.1% (n = 64) 52.5% (n = 31) 60.0% (n = 33) 0.423
SSRI 33.3% (n = 38) 30.5% (n = 18) 36.4% (n = 20) 0.508
NSAID 0.9% (n = 1) 1.7% (n = 1) 0.0% (n = 0) 0.332
BNP > 100 ng/L (n = 113) 49.6% 63.8% 34.5% 0.002
eGFR < 60 mL/min (n = 114) 61.4% 67.9% 54.5% 0.146
eGFR < 30 mL/min (n = 114) 11.4% 20.3% 1.8% 0.002
Transthyretin < 0.23 g/L (n = 114) 56.1% 62.7% 49.1% 0.143
CRP ≥ 10 mg/L (n = 112) 34.8% 45.8% 22.6% 0.010
Ferritin > 275 μg/L (n = 113) 15.0% 16.9% 13.0% 0.554
Transferrin < 1.9 g/L (n = 113) 3.5% 3.4% 3.7% 0.928
Hb hemoglobin, SD standard deviation, BMI Body Mass Index, ASA acetylsalicylic acid, SSRI selective serotonin re-uptake inhibitors, NSAID nonsteroidal anti-
inflammatory drugs, BNP B-type natriuretic peptide, eGFR estimated glomerular filtration rate, CRP C-reactive protein
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with and without anemia. Subjects with anemia did not
use drugs that could increase the bleeding risk more
frequently than non-anemic subjects (Table 1).
Among the male subjects with anemia the two-year
mortality was significantly higher (61%) than among the
subjects without anemia (29%, p = 0.001). Among female
subjects we found no statistical difference in two-year
survival (49% vs 43%, p = 0.340).
The difference in survival during the total follow-up
time (up to about 7 years) is presented as survival curves
for men and women with and without anemia (Fig. 2).
The difference in survival was not significant between
anemic and non-anemic subjects in total or after adjust-
ment for age, increased BNP and decreased eGFR.
However, when we stratified for sex, the difference in
survival during the follow-up period among male sub-
jects with or without anemia was significant (Hazard Ra-
tio 1.58) even when adjusting for age, increased BNP
and decreased eGFR (Table 2).
Among female subjects there was no significant correl-
ation between anemia and mortality but we noted a cor-
relation between increased BNP and mortality (Table 2).
When we investigated correlations between anemia
and some potential causes of anemia, we also found dif-
ferences between men and women (Table 1). Among
men we found correlations between anemia and ele-
vated BNP (>100 ng/L) and with severely reduced eGFR
(<30 ml/min). These correlations were not seen among
women. Among women we found correlations between
anemia and several markers of inflammation, such as
decreased transthyretin (<0.23 g/L), increased ferritin
(>204 μg/L), and increased CRP (≥10 mg/L). Among
men with anemia, there was a correlation with increased
CRP, but not with increased ferritin (>275 μg/L) or trans-
thyretin (<0.23 g/L, Table 1).
Prospective data after 12 months were used to com-
pare the quartiles in Hb change. In the lowest quartile
(decline more than 9 g/L) there was a higher mortality
Fig. 2 Survival curves for women and men with and without anemia
Table 2 Cox regression analysis including anemia, age, increased
BNP level and decreased eGFR in relation to mortality
Variable p-value HR CI 95% for HR
All subjects
Anemia Hb < 120 g/L and 130 g/L 0.066 1.225 0.987–1.521
Age (years) <0.001 1.051 1.033–1.070
BNP > 100 ng/L <0.001 1.751 1.403–2.187
eGFR < 60 mL/min 0.863 0.980 0.782–1.228
Women
Anemia Hb < 120 g/L 0.495 1.097 0.841–1.429
Age (years) <0.001 1.043 1.022–1.066
BNP > 100 ng/L <0.001 1.930 1.477–2.522
eGFR < 60 mL/min 0.286 0,866 0.666–1.128
Men
Anemia (Hb < 130 g/L) 0.028 1.580 1.049–2.379
Age (years) 0.001 1.072 1.031–1.115
BNP > 100 ng/L 0.137 1.367 0.906–2.064
eGFR < 60 ml/min 0.403 1.215 0.770–1.919
Hb hemoglobin, HR hazard ratio, CI confidence interval, BNP B-type natriuretic
peptide, eGFR estimated glomerular filtration rate
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during the following 12 months (36%) compared with
the other quartiles (18%, Table 3). The lowest quartile in
Hb change had higher Hb at baseline compared with the
highest quartile in Hb change (134 vs 113 g/L, p < 0.001),
but we found no other significant differences including
age, sex, number of drugs, Body Mass Index (BMI), eGFR,
BNP, MNA-SF and MMSE (Table 3).
Discussion
We found that anemia is common in people living in
nursing homes in Sweden. The overall anemia preva-
lence in this study was about the same, or lower, espe-
cially among women, compared to other earlier studies
in nursing homes [17–23].
In our sample anemia was more common in men than
in women. This difference is explained by the higher
anemia limit for men defined by WHO [8]. It has been
shown previously [14] that a higher overall prevalence of
anemia in older men results from the sex-specific cut-
points used to define anemia, with hemoglobin levels of
120 to 130 g/L (12–13 g/dL) defined as anemia in men
but normal in women. Even minor changes in anemia
criteria would result in significant increase or decrease
in the prevalence of anemia.
We found a higher mortality rate among men with
anemia compared to non-anemic men. This difference
was significant even when adjusting for the covariates
age, increased BNP and decreased eGFR. We did not see
the same higher mortality rate among women with
anemia.
We found no other studies describing sex differences
regarding anemia as a risk factor for mortality in a
nursing home population. Some other authors have
shown similar sex differences in Hb to those in this
study, both a higher anemia rate in elderly men than in
women [6, 10, 14, 16, 34] using the WHO anemia
limits, and a slightly higher mortality risk in anemic
men than in women [16]. However, three of these studies
were published in 1987–1999 and none of these studies
was performed in a nursing home population. A Japanese
case–control study performed in 1990–1996 on nursing
home anemia subjects showed similar survival curves
during a follow-up period for death rates of 5 years.
The study was smaller, based on a lower anemia limit
(110 g/L) for both sexes, involved few men and did not
describe the sex differences [35].
In our study increased BNP or decreased eGFR were
more common among men with anemia, but there was a
higher mortality even after adjustment for these variables.
This indicates that men in nursing homes with anemia
may have more severe underlying causes of anemia than
women. This is consistent with previous conclusions that
the higher frequency of anemia in men can be explained
by a higher prevalence of underlying diseases [16]. How-
ever, we cannot rule out the possibility that our results
regarding gender differences and anemia versus mortality
could be explained by that the gender specific cut-off
levels for anemia is not relevant in this population.
Furthermore, the observational design of this study pre-
cludes any definite conclusions about causality.
We also found that Hb decline during the last year was
correlated with a doubled one-year mortality. Interestingly
a higher Hb value was more associated with Hb decline
than were low Hb values. These results are consistent
Table 3 Quartiles of change in Hb levels during 12 months and the subsequent 1-year mortality
Hb change range (g/L) Quartile 1: Quartile 2: Quartile 3: Quartile 4: p-value
−45 – –10 (n = 58) −9 – −2 (n = 55) −1 – +6 (n = 56) +7 – +28 (n = 51) (comparing q1 with q4)
Hb at baseline in men (g/L)
mean ± SD
134.3 ± 11.0 (n = 22) 132.6 ± 9.9 (n = 16) 127.7 ± 14.0 (n = 15) 112.9 ± 11.3 (n = 12) p < 0.001
Hb at baseline in women (g/L)
mean ± SD
128.2 ± 10.8 (n = 36) 127.0 ± 13.0 (n = 39) 123.4 ± 10.9 (n = 41) 120.5 ± 13.1 (n = 39) p = 0.007
Male sex (%) 37.9 (n = 22) 29.1 (n = 16) 26.8 (n = 15) 23.5 (n = 12) P = 0.10
Age (years) 83.4 ± 8.3 (n = 58) 83.6 ± 6.3 (n = 55) 83.1 ± 7.3 (n = 56) 85.7 ± 5.8 (n = 51) p = 0.10
Number of drugs, mean ± SD 7.2 ± 3.0 (n = 58) 6.7 ± 2.5 (n = 55) 6.8 ± 3.1 (n = 56) 6.7 ± 3.5 (n = 51) p = 0.47
BMI (kg/m2) mean ± SD 25.5 (±5.1) (n = 58) 25.6 ± 5.0 (n = 55) 25.0 ± 4.4 (n = 56) 24.9 (±4.8) (n = 51) p = 0.53
eGFR (mL/min) 56.8 ± 16.1 (n = 58) 55.7 ± 14.3 (n = 55) 51.9 ± 14.4 (n = 56) 54.2 ± 15.7 (n = 51) p = 0.38
BNP (ng/L) mean ± SD 139.4 ± 190.2 (n = 57) 117.8 ± 166.4 (n = 54) 159.6 ± 235.8 (n = 55) 128.6 ± 114.0 (n = 51) p = 0.72
MNA-SF initial result mean ± SD 10.5 ± 2.3 (n = 58) 10.9 ± 2.2 (n = 55) 10.8 ± 2.1 (n = 55) 10.4 ± 2.8 (n = 51) p = 0.74
MMSE result mean ± SD 16.2 ± 6.7 (n = 49) 17.6 ± 6.0 (n = 50) 17.8 ± 6.5 (n = 49) 17.9 ± 6.2 (n = 49) p = 0.20
1 year mortality (%) 36.2 18.2 17.9 17.6
p = 0.032 (q1 vs q2) p = 0.028 (q1 vs q3) P = 0.030 (q1 vs q4)
Hb hemoglobin, q quartile, SD standard deviation, BMI Body Mass Index, BNP B-type natriuretic peptide, eGFR estimated glomerular filtration rate, MNA-SF Short-form
Mini-nutritional assessment, MMSE Mini Mental State Examination
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with a previous study in a community-dwelling elderly
but younger population (mean age 72.1 years) [36]. This
means that it is difficult to predict declining Hb based
on the current Hb level. Neither did we find other risk
factors for Hb decline.
A low Hb value in an older person living in nursing
home is a marker of disease and a warning signal for
death, especially among men. A higher Hb value is no
protection against a drop in Hb, which also is a separate
warning signal and correlated with higher mortality.
There may be a risk that low Hb values or Hb decline is
overlooked and not further investigated in a nursing
home population. The symptoms of anemia are vague in
elderly patients and the onset of symptoms is usually in-
sidious [11]. Other contributing factors may be complex
comorbidity, a belief that the investigation results do not
change treatment options and lack of time.
This study has some limitations. First, this is a rather
small sample of nursing home residents especially when
separating men and women in the analysis. Second, there
may be a selection bias initially because palliative patients
were excluded. The reason for moving into a nursing
home may differ between men and women. Somatic dis-
ease may theoretically be a more common reason for
nursing home care among men, while psychosocial factors
such as loneliness and need for stimulation may matter
more to women as they live longer. The lower anemia rate
among the women in this study compared to other nurs-
ing home studies may support this hypothesis.
Third, the sample of nursing homes used was not
randomly selected, but rather selected for reasons of
convenience from three different areas in Sweden, with
persons in nursing homes whose staff were interested in
joining the project being asked to participate. However,
the nursing homes included did not differ notably from
other nursing homes in Sweden [28].
Since anemia is common among older adults, especially
in nursing homes, further research is needed in this area.
More knowledge about causes of anemia in a nursing
home population would be valuable. More research is also
required to establish guidelines on how to handle anemia
in a multimorbid nursing home population.
Conclusions
Our study suggests that anemia is common in nursing
home residents in Sweden, as shown in previous studies
in other countries. In our sample anemia was more fre-
quent among men for whom it was related to a higher
mortality.
A rapid Hb decline was associated with higher mortality.
Hb decline was associated with higher Hb at baseline.
According to our results it seems important to monitor
Hb regularly in a nursing home population regardless of
earlier Hb values.
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